After settlement of the third case to head to the courtroom in Philadelphia’s Risperdal mass tort, the lead trial attorney for the plaintiffs said it is too soon to expect a global resolution of the litigation.
On May 27, the day opening arguments were scheduled in Walker v. Janssen Pharmaceuticals, the case settled for a confidential amount, according to Thomas R. Kline of Kline & Specter, who is trying Risperdal cases with co-counsel Christopher A. Gomez and Stephen A. Sheller of Sheller P.C.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
